Preconditioning protects against oxidative injury involving hypoxia-inducible factor-1 and vascular endothelial growth factor in cultured astrocytes

European Journal of Pharmacology

Volumn 633, Issue 1-3, 2010, Pages 24-32

  Chu, Percy W Y ^a   Beart, Philip M ^a   Jones, Nicole M ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Desferrioxamine; HIF 1 (hypoxia inducible factor 1) target gene; Neuroprotection; Oxidative stress; Prolyl hydroxylase; Tolerance

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; BENZOIC ACID DERIVATIVE; CYCLOHEXIMIDE; DEFEROXAMINE; ETHYL 3,4 DIHYDROBENZOIC ACID; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ASTROCYTE; BRAIN DISEASE; CELL ISOLATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; CYCLOHEXIMIDE; CYTOPROTECTION; DEFEROXAMINE; DRUG INTERACTIONS; ENZYME INHIBITORS; HYDROGEN PEROXIDE; HYDROXYBENZOIC ACIDS; HYPOXIA-INDUCIBLE FACTOR 1; INDAZOLES; MICE; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77949917152     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.02.008     Document Type: Article

References (50)

1. Behzadian M.A., Wang X.L., Al-Shabrawey M., Caldwell R.B. Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia 1998, 24:216-225.
2. Bergeron M., Yu A.Y., Solway K.E., Semenza G.L., Sharp F.R. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci. 1999, 11:4159-4170.
3. Brockington A., Lewis C., Wharton S., Shaw P.J. Vascular endothelial growth factor and the nervous system. Neuropathol. Appl. Neurobiol. 2004, 30:427-446.
4. Bruick R.K., McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001, 294:1337-1340.
5. Chan D.A., Sutphin P.D., Denko N.C., Giaccia A.J. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J. Biol. Chem. 2002, 277:40112-40117.
6. Chavez J.C., Baranova O., Lin J., Pichiule P. The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J. Neurosci. 2006, 26:9471-9481.
7. Chun Y.S., Yeo E.J., Choi E., Teng C.M., Bae J.M., Kim M.S., Park J.W. Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells. Biochem. Pharmacol. 2001, 61:947-954.
8. Desagher S., Glowinski J., Premont J. Astrocytes protect neurons from hydrogen peroxide toxicity. J. Neurosci. 1996, 16:2553-2562.
9. Dirnagl U., Simon R.P., Hallenbeck J.M. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 2003, 26:248-254.
10. Diwakarla S., Nagley P., Hughes M.L., Chen B., Beart P.M. Differential insult-dependent recruitment of the intrinsic mitochondrial pathway during neuronal programmed cell death. Cell. Mol. Life Sci. 2009, 66:156-172.
11. Dringen R., Hamprecht B. Involvement of glutathione peroxidase and catalase in the disposal of exogenous hydrogen peroxide by cultured astroglial cells. Brain Res. 1997, 759:67-75.
12. Dringen R., Pawlowski P.G., Hirrlinger J. Peroxide detoxification by brain cells. J. Neurosci. Res. 2005, 79:157-165.
13. Drukarch B., Schepens E., Jongenelen C.A., Stoof J.C., Langeveld C.H. Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency. Brain Res. 1997, 770:123-130.
14. Gidday J.M. Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 2006, 7:437-448.
15. Hamrick S.E., McQuillen P.S., Jiang X., Mu D., Madan A., Ferriero D.M. A role for hypoxia-inducible factor-1alpha in desferoxamine neuroprotection. Neurosci. Lett. 2005, 379:96-100.
16. Helton R., Cui J., Scheel J.R., Ellison J.A., Ames C., Gibson C., Blouw B., Ouyang L., Dragatsis I., Zeitlin S., Johnson R.S., Lipton S.A., Barlow C. Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J. Neurosci. 2005, 25:4099-4107.
17. Hirrlinger J., Resch A., Gutterer J.M., Dringen R. Oligodendroglial cells in culture effectively dispose of exogenous hydrogen peroxide: comparison with cultured neurones, astroglial and microglial cells. J. Neurochem. 2002, 82:635-644.
18. Ijichi A., Sakuma S., Tofilon P.J. Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures. Glia 1995, 14:87-93.
19. Jones N.M., Kardashyan L., Callaway J.K., Lee E.M., Beart P.M. Long-term functional and protective actions of preconditioning with hypoxia, cobalt chloride and desferrioxamine against hypoxic-ischemic injury in neonatal rats. Pediatr. Res. 2008, 63:620-624.
20. Kim H.L., Yeo E.J., Chun Y.S., Park J.W. A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent. Int. J. Oncol. 2006, 29:255-260.
21. Ko F.N., Wu C.C., Kuo S.C., Lee F.Y., Teng C.M. YC-1, a novel activator of platelet guanylate cyclase. Blood 1994, 84:4226-4233.
22. Lamigeon C., Bellier J.P., Sacchettoni S., Rujano M., Jacquemont B. Enhanced neuronal protection from oxidative stress by coculture with glutamic acid decarboxylase-expressing astrocytes. J. Neurochem. 2001, 77:598-606.
23. Liddell J.R., Robinson S.R., Dringen R. Endogenous glutathione and catalase protect cultured rat astrocytes from the iron-mediated toxicity of hydrogen peroxide. Neurosci. Lett. 2004, 364:164-167.
24. Maragakis N.J., Rothstein J.D. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2006, 2:679-689.
25. McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 1980, 85:890-902.
26. Moldrich R.X., Aprico K., Diwakarla S., O'Shea R.D., Beart P.M. Astrocyte mGlu(2/3)-mediated cAMP potentiation is calcium sensitive: studies in murine neuronal and astrocyte cultures. Neuropharmacology 2002, 43:189-203.
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
28. Mu D., Chang Y.S., Vexler Z.S., Ferriero D.M. Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. Exp. Neurol. 2005, 195:407-415.
29. Prieto M., Alonso G. Differential sensitivity of cultured tanycytes and astrocytes to hydrogen peroxide toxicity. Exp. Neurol. 1999, 155:118-127.
30. Rajapakse N., Kis B., Horiguchi T., Snipes J., Busija D. Diazoxide pretreatment induces delayed preconditioning in astrocytes against oxygen glucose deprivation and hydrogen peroxide-induced toxicity. J. Neurosci. Res. 2003, 73:206-214.
31. Rankin E.B., Biju M.P., Liu Q., Unger T.L., Rha J., Johnson R.S., Simon M.C., Keith B., Haase V.H. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J. Clin. Invest. 2007, 117:1068-1077.
32. Rosenstein J.M., Krum J.M. New roles for VEGF in nervous tissue-beyond blood vessels. Exp. Neurol. 2004, 187:246-253.
33. Sasaki T., Majamaa K., Uitto J. Reduction of collagen production in keloid fibroblast cultures by ethyl-3,4-dihydroxybenzoate. Inhibition of prolyl hydroxylase activity as a mechanism of action. J. Biol. Chem. 1987, 262:9397-9403.
34. Semenza G.L. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 2001, 7:345-350.
35. Semenza G.L., Roth P.H., Fang H.M., Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 1994, 269:23757-23763.
36. Sharp F.R., Bernaudin M. HIF1 and oxygen sensing in the brain. Nat. Rev. Neurosci. 2004, 5:437-448.
37. Siddiq A., Ayoub I.A., Chavez J.C., Aminova L., Shah S., LaManna J.C., Patton S.M., Connor J.R., Cherny R.A., Volitakis I., Bush A.I., Langsetmo I., Seeley T., Gunzler V., Ratan R.R. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J. Biol. Chem. 2005, 280:41732-41743.
38. Sinor A.D., Irvin S.M., Cobbs C.S., Chen J., Graham S.H., Greenberg D.A. Hypoxic induction of vascular endothelial growth factor (VEGF) protein in astroglial cultures. Brain Res. 1998, 812:289-291.
39. Storkebaum E., Lambrechts D., Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 2004, 26:943-954.
40. Trendelenburg G., Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 2005, 50:307-320.
41. Vangeison G., Carr D., Federoff H.J., Rempe D.A. The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1 alpha in neurons and astrocytes. J. Neurosci. 2008, 28:1988-1993.
42. Wang G.L., Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 1995, 270:1230-1237.
43. Wang J., Buss J.L., Chen G., Ponka P., Pantopoulos K. The prolyl 4-hydroxylase inhibitor ethyl-3, 4-dihydroxybenzoate generates effective iron deficiency in cultured cells. FEBS Lett. 2002, 529:309-312.
44. Warnecke C., Zaborowska Z., Kurreck J., Erdmann V.A., Frei U., Wiesener M., Eckardt K.U. Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J. 2004, 18:1462-1464.
45. Woo K.J., Lee T.J., Park J.W., Kwon T.K. Desferrioxamine, an iron chelator, enhances HIF-1alpha accumulation via cyclooxygenase-2 signaling pathway. Biochem. Biophys. Res. Commun. 2006, 343:8-14.
46. Wright G., Higgin J.J., Raines R.T., Steenbergen C., Murphy E. Activation of the prolyl hydroxylase oxygen-sensor results in induction of GLUT1, heme oxygenase-1, and nitric-oxide synthase proteins and confers protection from metabolic inhibition to cardiomyocytes. J. Biol. Chem. 2003, 278:20235-20239.
47. Yang D.I., Chen S.D., Yang Y.T., Ju T.C., Xu J.M., Hsu C.Y. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1. Br. J. Pharmacol. 2004, 141:988-996.
48. Yang Y.T., Ju T.C., Yang D.I. Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells. J. Neurochem. 2005, 93:513-525.
49. Yu F., White S.B., Zhao Q., Lee F.S. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:9630-9635.
50. Zaman K., Ryu H., Hall D., O'Donovan K., Lin K.I., Miller M.P., Marquis J.C., Baraban J.M., Semenza G.L., Ratan R.R. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J. Neurosci. 1999, 19:9821-9830.